Skip to main content
SpringerLink
Log in

Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy

  • Short Reports
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Ceftriaxone, a third-generation cephalosporin, is known to induce reversible precipitations in the gallbladder of children. In general, radiologic signs and symptoms will develop after 9–11 days of treatment. The authors repport a case where 48h of therapy were sufficient to develop a biliary pseudolithiasis. Clinicians and radiologists should be aware of this complication which mimics true cholelithiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Avidsson A, Alvan G, Angelin B, Borga O, Nord CE (1982) Ceftriaxone: renal and biliary excretion and effect on colon microflora. J Antimicrob Chemother 14: 213–217

    Google Scholar 

  2. Schaad UB, Wedgwood-Krucko J, Tschaeppeler H (1988) Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet II: 1411–1413

    Article  Google Scholar 

  3. Heim-Duthoy KL, Caperton EM, Pollock R, Matzke GR, Enthoven D, Peterson PK (1990) Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother 34: 1146–1149

    PubMed  Google Scholar 

  4. Park HZ, Lee SP, Schy AL (1991) Ceftriaxone associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology 100: 1665–1670

    PubMed  Google Scholar 

  5. Lee SP, Lipsky BA, Teefey SA (1990) Gallbladder sludge and antibiotics. Pediatr Infect Dis J 9: 422–423

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, CHU de Sherbrooke, 3001 12e Avenue Nord, J1H 5N4, Sherbrooke, Quebec, Canada

    C. Blais

  2. Division ofInfectious Diseases, CHU de Sherbrooke, 3001 12e Avenue Nord, JIH 5N4, Sherbrooke, Quebec, Canada

    R. Duperval

Authors
  1. C. Blais
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Duperval
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blais, C., Duperval, R. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy. Pediatr Radiol 24, 218–219 (1994). https://doi.org/10.1007/BF02012198

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02012198

Keywords

Search

Navigation